1. Home
  2. ROCK vs MYGN Comparison

ROCK vs MYGN Comparison

Compare ROCK & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gibraltar Industries Inc.

ROCK

Gibraltar Industries Inc.

HOLD

Current Price

$51.04

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$7.22

Market Cap

625.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROCK
MYGN
Founded
1972
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
625.5M
IPO Year
1993
1995

Fundamental Metrics

Financial Performance
Metric
ROCK
MYGN
Price
$51.04
$7.22
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$11.82
AVG Volume (30 Days)
405.5K
1.1M
Earning Date
10-30-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$1,383,811,000.00
$825,300,000.00
Revenue This Year
N/A
$0.10
Revenue Next Year
$6.98
$5.28
P/E Ratio
$11.43
N/A
Revenue Growth
23.49
0.21
52 Week Low
$42.86
$3.76
52 Week High
$75.08
$15.47

Technical Indicators

Market Signals
Indicator
ROCK
MYGN
Relative Strength Index (RSI) 45.15 50.91
Support Level $48.50 $7.15
Resistance Level $52.33 $7.43
Average True Range (ATR) 1.60 0.30
MACD 0.81 0.02
Stochastic Oscillator 80.23 29.31

Price Performance

Historical Comparison
ROCK
MYGN

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Share on Social Networks: